Send to a Friend Font Size: Increase Decrease

OGN and 2E8 Related Headlines

Apr 29, 2026 10:00AM European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
Apr 29, 2026 05:30AM European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

OGN and 2E8 Related Press Releases

Apr 29, 2026 10:00AM European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
Apr 29, 2026 05:30AM European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

OGN and 2E8 Related SEC Filings